temozolomide has been researched along with Barrett Esophagus in 1 studies
Barrett Esophagus: A condition with damage to the lining of the lower ESOPHAGUS resulting from chronic acid reflux (ESOPHAGITIS, REFLUX). Through the process of metaplasia, the squamous cells are replaced by a columnar epithelium with cells resembling those of the INTESTINE or the salmon-pink mucosa of the STOMACH. Barrett's columnar epithelium is a marker for severe reflux and precursor to ADENOCARCINOMA of the esophagus.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Jammula, S | 1 |
Katz-Summercorn, AC | 1 |
Li, X | 1 |
Linossi, C | 1 |
Smyth, E | 1 |
Killcoyne, S | 1 |
Biasci, D | 1 |
Subash, VV | 1 |
Abbas, S | 1 |
Blasko, A | 1 |
Devonshire, G | 1 |
Grantham, A | 1 |
Wronowski, F | 1 |
O'Donovan, M | 1 |
Grehan, N | 1 |
Eldridge, MD | 1 |
Tavaré, S | 1 |
Fitzgerald, RC | 1 |
1 other study available for temozolomide and Barrett Esophagus
Article | Year |
---|---|
Identification of Subtypes of Barrett's Esophagus and Esophageal Adenocarcinoma Based on DNA Methylation Profiles and Integration of Transcriptome and Genome Data.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Barrett Esophagus; Cyclin E; Disease Progression; DNA M | 2020 |